These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12869132)

  • 1. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
    Jakobsen H; Jonsdottir I
    Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustaining immunity after immunization against encapsulated bacteria.
    Blanchard-Rohner G; Pollard AJ
    Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive immunization for the prevention of otitis media.
    Englund JA; Glezen WP
    Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.
    Adderson EE
    Springer Semin Immunopathol; 2001 Dec; 23(4):387-403. PubMed ID: 11826616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination and otitis media.
    Karma P
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(2):80-5. PubMed ID: 12021498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.
    Jakobsen H; Bjarnarson S; Del Giudice G; Moreau M; Siegrist CA; Jonsdottir I
    Infect Immun; 2002 Mar; 70(3):1443-52. PubMed ID: 11854231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
    Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
    J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
    Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
    Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
    Nieminen T; Käyhty H; Leroy O; Eskola J
    Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines against polysaccharide antigens.
    Lesinski GB; Westerink MA
    Curr Drug Targets Infect Disord; 2001 Nov; 1(3):325-34. PubMed ID: 12455405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
    Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
    Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
    Bröker M; Berti F; Schneider J; Vojtek I
    Vaccine; 2017 Jun; 35(25):3286-3294. PubMed ID: 28487056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections.
    Raby R; Blaiss M; Gross S; Herrod HG
    J Allergy Clin Immunol; 1996 Aug; 98(2):451-9. PubMed ID: 8757223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan.
    Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM
    J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.
    Jakobsen H; Saeland E; Gizurarson S; Schulz D; Jónsdóttir I
    Infect Immun; 1999 Aug; 67(8):4128-33. PubMed ID: 10417183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.